Searched for
ABBOTT LABORATORIES
Trump’s more than 3,700 trades astonish Wall Street insiderPresident Trump's latest financial disclosures reveal over 3,700 trades totaling tens of millions of dollars in the first quarter. These tr...- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Whoop raises $575 million at a $10 billion valuation on its way to an IPOWhoop, the maker of popular screenless fitness bands, is now valued at $10.1 billion after raising an additional $575 million, a new milest...
- Abbott Labs to face trial on infant formulaA Chicago trial begins Wednesday. Four families claim Abbott Laboratories' baby formula caused a dangerous bowel disease in their premature...
- Abbott in talks to buy exact sciences as cologuard maker’s shares jumpAbbott Laboratories is in talks to buy Exact Sciences, a company known for its Cologuard cancer test. Reports say the possible deal is in a...
- FDA approves 15 minute, five dollar coronavirus test that doesn't need specialty equipmentThe 15-minute test from Abbott Laboratories will sell for $5, giving it a competitive edge over similar tests that need to be popped into a...
- CCI clears Abbott-St Jude deal subject to 'voluntary remedies'In a tweet, Competition Commission of India (CCI) said it has approved the "proposed combination between St Jude Medical and Abbott Laborat...
- Abbott Labs up 100% in 15 months, still not expensive: Mehraboon IraniLooking at the numbers, which the management was talking about, the stock still does not look very expensive, says Irani.
- A whole of pharma stocks are relatively expensive to the over all market: Mehraboon Irani'On the whole, a whole of pharma stocks, quite a few of them including some of the bigger names, according to me, are relatively expensive'
- Abbott Laboratories set to consolidate India operationsThe $39-bn pharma giant Abbott Labs will consolidate India operations under a new leadership, as part of a plan to tap operational synergie...
- Abbott Laboratories in pact with Biocon to develop nutrition productsAbbott Laboratories will collaborate with Bangalore-based Biocon to establish a research and development centre to develop nutrition produc...
- Abbott invests Rs 61 cr in social initiatives in IndiaDrug maker Abbott India today said it has invested over Rs 61 crore in the country towards various social activities.
- American firm Abbott consolidates top position in Indian drug marketAmerican firm Abbott Laboratories consolidated its top position in the Indian drug retail market by growing at a faster than its closest co...
- Abbott, Ranbaxy settle patent suitThe financial upside for Ranbaxy will depend on several factors since there are 3 other drugmakers wanting to launch their versions of the ...
- Abbott patent application for HIV drug spurnedBesides I-MAK, a few local HIV drug makers such as Cipla and US-based Mylan-owned Matrix Laboratories had also opposed Abbott's attempt to ...
- Abbott plans 3,000 job cuts tied to Solvay dealAbbott Laboratories says it will eliminate 3,000 jobs and take almost $1.3 billion in charges over the next two years as it integrates its ...
- Piramal Health to receive USD 2.12-bn in 4-6 weeks from AbbottAjay Piramal-controlled Piramal Healthcare expects to get USD 2.12-billion in 4-6-weeks following completion of the sale transaction of its...
- Fire damages Wockhardt's unit at AnkleshwarA fire at pharmaceutical major Wockhardt’s Rs 300-crore Ankleshwar facility damaged one of its six manufacturing plants.
- Abbott makes open offer for 20 pc in Solvay Pharma IndiaUS-based pharmaceutical firm Abbott Laboratories announced completing the acquisition of the global drug business of Solvay SA, consequent ...
- Abbott to cut 1,000 jobs from diagnostic unitDrug and medical device maker Abbott Laboratories will cut 1,000 jobs as part of a multiyear effort to lower spending on its medical testin...
Load More
